Exelixis Inc. Stock
Exelixis Inc. Stock
A loss of -1.260% shows a downward development for Exelixis Inc..
Exelixis Inc. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 26 € shows a positive potential of 35.95% compared to the current price of 19.13 € for Exelixis Inc..
Pros and Cons of Exelixis Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Exelixis Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Exelixis Inc. | -1.260% | -0.206% | -8.373% | 5.789% | -11.472% | -3.536% | 11.258% |
| Ironwood Pharmaceuticals | 0.850% | 0.000% | -19.048% | -38.342% | -41.667% | -41.089% | - |
| Novocure Ltd | -7.550% | 11.578% | 84.670% | -71.506% | 46.830% | -85.900% | - |
| Iovance Biotherapeutics Inc. | -0.020% | -4.136% | -10.611% | 39.612% | 21.696% | -35.884% | - |
Comments
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Show more
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at TD Cowen from $25.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for EXEL provided by MarketBeat
News
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q1 2024 Earnings CallApr 30, 2024, 5:00 p.m. ET
Operator
Source Fool.com
2 Stocks Under $30 to Buy and Hold
What is a reasonable sum of money to start investing in stocks? $10,000? $1,000? $500? The truth is, thanks to online brokers who now offer trades at low or no fees and fractional shares, investors